- Home
- LIQT vs MBRX Comparison
LIQT vs MBRX Comparison
Compare LIQT & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- MBRX
- Stock Information
- Founded
- LIQT 2004
- MBRX 2015
- Country
- LIQT Denmark
- MBRX United States
- Employees
- LIQT N/A
- MBRX N/A
- Industry
- LIQT Industrial Machinery/Components
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- LIQT Technology
- MBRX Health Care
- Exchange
- LIQT Nasdaq
- MBRX Nasdaq
- Market Cap
- LIQT 16.1M
- MBRX 17.1M
- IPO Year
- LIQT N/A
- MBRX 2016
- Fundamental
- Price
- LIQT $2.60
- MBRX $0.39
- Analyst Decision
- LIQT Strong Buy
- MBRX Strong Buy
- Analyst Count
- LIQT 2
- MBRX 4
- Target Price
- LIQT $4.80
- MBRX $5.00
- AVG Volume (30 Days)
- LIQT 20.6K
- MBRX 4.8M
- Earning Date
- LIQT 11-13-2025
- MBRX 11-07-2025
- Dividend Yield
- LIQT N/A
- MBRX N/A
- EPS Growth
- LIQT N/A
- MBRX N/A
- EPS
- LIQT N/A
- MBRX N/A
- Revenue
- LIQT $15,459,242.00
- MBRX N/A
- Revenue This Year
- LIQT $36.89
- MBRX N/A
- Revenue Next Year
- LIQT $16.33
- MBRX N/A
- P/E Ratio
- LIQT N/A
- MBRX N/A
- Revenue Growth
- LIQT N/A
- MBRX N/A
- 52 Week Low
- LIQT $1.34
- MBRX $0.25
- 52 Week High
- LIQT $3.20
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- LIQT 63.09
- MBRX 39.16
- Support Level
- LIQT $2.25
- MBRX $0.36
- Resistance Level
- LIQT $2.88
- MBRX $0.42
- Average True Range (ATR)
- LIQT 0.18
- MBRX 0.03
- MACD
- LIQT 0.06
- MBRX 0.00
- Stochastic Oscillator
- LIQT 72.00
- MBRX 61.71
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.